Picture of Dermapharm Holding SE logo

DMP Dermapharm Holding SE Balance Sheet

0.000.00%
de flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual balance sheet for Dermapharm Holding SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments214117123173162
Net Total Accounts Receivable
Net Total Receivables36.952.757.884.2103
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets371353400519534
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment80.9133200222226
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets7051,0451,2241,4071,413
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities146102133156218
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities452766902910881
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity252279322497532
Total Liabilities & Shareholders' Equity7051,0451,2241,4071,413
Total Common Shares Outstanding